PRESS RELEASE
ReferenceCellTM Platform for Improved High-Content Screening Will be Assessed by Leading Industry Consortium
Cambridge Healthtech Associates and CYTOO Announce a Collaborative Technology Evaluation

Needham, Massachusetts (USA) and Grenoble (FRA), 27 April 2011 : The Drug Safety Executive Council (DSEC), an industry membership run by Cambridge Healthtech Associates (CHA), together with CYTOO, a provider of innovative products for the life science research and drug discovery markets with an emphasis in cell-based assays, high-content analysis and cell screening, today announced a new program as part of DESC's Technology Evaluation Consortium.  Read more